文献速递血栓与止血

儿童癌症幸存者晚期静脉血栓栓塞事件:圣犹达终身队列研究报告

Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St Jude Lifetime Cohort Study.
PubMed 文献 · Blood Adv · 2026-09-30

该研究基于圣犹达终身队列(N=5229)评估儿童癌症幸存者晚期(诊断后≥5年)静脉血栓栓塞(VTE)的患病率及危险因素。幸存者晚期VTE患病率为1.8%(95%CI 1.5-2.2%),显著高于社区对照的0.7%(95%CI 0.2%-1.6%,p=0.02)。调整模型显示胸部放疗(OR 2.0,95%CI 1.01-4.0)、腹部放疗(OR 2.2,95%CI 1.04-4.8)及性激素使用(OR 2.2,95%CI 1.2-3.7)与晚期VTE相关。

要点

  • 儿童癌症幸存者晚期VTE患病率1.8%,高于无癌症史对照的0.7%。
  • 胸部或腹部放疗及性激素使用与晚期VTE风险升高相关。
  • 霍奇金淋巴瘤幸存者诊断后35年累积发病率最高(7.6%)。

核心结论

  • 儿童癌症幸存者晚期VTE患病率和风险升高,尤其接受放疗或使用性激素者。

研究设计与样本

  • 圣犹达终身队列研究,纳入5229名儿童癌症幸存者,并与737名无儿童癌症史的社区对照比较。

主要发现

  • 108次VTE中,53.7%位于肢体(上肢7次,下肢51次),其次为肺(35.2%)、腹部(4.6%)、颈部(2.8%)、脑静脉窦(0.9%)和其他(2.8%)。
  • 霍奇金淋巴瘤幸存者诊断后35年累积发病率最高,为7.6%(95%CI 4.5%-11.8%)。
  • 调整模型中,晚期VTE与胸部放疗(OR 2.0,95%CI 1.01-4.0)、腹部放疗(OR 2.2,95%CI 1.04-4.8)及性激素使用(OR 2.2,95%CI 1.2-3.7)相关。
  • 晚期VTE与早期(诊断后<5年)VTE无关联(p=0.7)。

临床怎么用

  • 将胸部或腹部放疗史及性激素使用纳入儿童癌症幸存者的VTE风险评估,以指导监测、预防或干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Survivors of childhood cancer are at risk of adverse sequelae related to prior therapies. We describe the prevalence of and risk factors for late (≥5 years from cancer diagnosis) venous thromboembolism (VTE) among participants of the St. Jude Lifetime Cohort (N=5229). Prevalence of late VTE was compared between survivors and community controls (N=737) without a history of childhood cancer. Associations with treatment and clinical factors were assessed in multivariable regression models. Ninety-four (1.8% 95% CI 1.5-2.2%) survivors [median age at cancer diagnosis 9.4 years (range:0.0-20.9); 38.5 years (12-65.9) at evaluation] had 108 VTEs vs. 5 (0.7% 95% CI 0.2%-1.6%) among controls (p=0.02) (31.1 years [12.1-70.2] at evaluation). The cumulative incidence 35 years from diagnosis was highest among survivors of Hodgkin lymphoma (7.6% [95% CI 4.5%-11.8%]). Fifty-eight of 108 (53.7%) were in an extremity (upper=7, lower=51) followed by pulmonary (38, 35.2%), abdomen (n=5, 4.6%), neck (n=3, 2.8%), cerebral sinus (n=1, 0.9%), other (n=3, 2.8%). No associations with early (<5 years from cancer diagnosis) VTE were identified (p=0.7). In adjusted models, late VTE was associated with exposure to chest (OR 2.0 95% CI 1.01-4.0) and abdominal (OR 2.2 95% CI 1.04-4.8) radiation, not combined radiation fields (OR 1.2 95% CI 0.7-2.0), and sex hormone use (OR 2.2 95% CI 1.2-3.7). The prevalence of and risk for VTE are elevated among survivors of childhood cancer, particularly those treated with radiation or using sex hormones. Incorporating these factors into risk assessments may guide monitoring, prophylaxis, or interventions, particularly in high-risk situations.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Jesudas R, Wang L, Chen Y, et al. Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St Jude Lifetime Cohort Study. Blood Adv. 2026. PMID: 42815881. doi:10.1182/bloodadvances.2026020935

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。